Indefinite Delivery Contract SPE2DX16D2916

Award Date 3/3/16
Last Date to Order 12/31/25
Federal Agency
Medical Supply Chain
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is valued at up to $4,999,999.99 through December 31, 2025. The contract provides for the delivery of a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits...
The Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a critical vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The $999,999,999 single-award IDC, which runs through November 2026, encompasses the delivery of specialty medications, brand-name and generic drugs, vaccines, syringes,...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The single-award IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at up to $999,999,999.00, runs through December 31, 2025 and serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contracted items include specialty...
This federal Indefinite Delivery Contract (IDC), awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, aims to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The $999,999,999 IDC, which runs through November 2026, serves as the primary vehicle for Amerisourcebergen to deliver specialty medications, brand-name and generic drugs,...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at up to $999,999,999.00 through December 2025, is intended to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. The contracted items include specialty medications, brand-name and generic drugs, vaccines, and critical...
The Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. is a single-award contract valued at $999,999,999 through November 2026. This contract serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses a broad spectrum of critical medical commodities, including...
The Indefinite Delivery Contract (IDC) SPE2DX15D3923 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The single-award IDC, valued at up to $999,999,999.00, enables the DLA to efficiently procure a wide range of pharmaceutical products and medical supplies to support military treatment facilities and programs worldwide. Key products include specialty medications, brand-name and generic...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The single-award IDC, valued at up to $4,999,999.00, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract scope includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits...
The Indefinite Delivery Contract (IDC) SPE2DX16D3924 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The single-award contract, valued at up to $4,999,999.00, runs through November 2023 and covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract includes specialty medications, brand-name and generic drugs,...

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at up to $4,999,999.99, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has an ultimate completion date of December 31, 2025.

The IDC serves as the primary vehicle for Amerisourcebergen to provide critical medical commodities to the DLA, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. Additionally, Amerisourcebergen holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs. These contracts enable the efficient government procurement of essential pharmaceutical and medical supplies to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 7/2/25, 11:05 PM